Filter
397
Text search:
International
Union
against
Tuberculosis
and
Lung
Disease
Featured
41
80
Language
Document type
298
39
33
13
7
4
2
1
Countries
23
11
11
11
7
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
89
59
21
10
9
3
2
Toolboxes
253
10
9
9
8
8
6
5
5
5
4
4
4
3
2
2
2
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
30 October 2017
The Open Infectious Diseases Journal, 2010, 4, 33-37
guidance for health managers, health workers, and activists
A Handbook for country programmes
Public health Panoram, Vol.2 Issue 1 March 2016
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
Systematic screening for active tuberculosis: an operational guide.
Pathak et al. (2016), PeerJ, DOI 10.7717/peerj.1738; 1-14
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Accessed: 08.10.2019
Experience of national TB partnerships
Sixth edition
2007
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
